Detalles de la búsqueda
1.
Management of patients with presumed germline pathogenic variant from tumor-only genomic sequencing: A retrospective analysis at a single facility.
J Hum Genet
; 68(6): 399-408, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36804482
2.
Durvalumab after chemoradiotherapy for locally advanced non-small cell lung cancer prolonged distant metastasis-free survival, progression-free survival and overall survival in clinical practice.
BMC Cancer
; 22(1): 364, 2022 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35379201
3.
Results of the non-small cell lung cancer part of a phase III, open-label, randomized trial evaluating topical corticosteroid therapy for facial acneiform dermatitis induced by EGFR inhibitors: stepwise rank down from potent corticosteroid (FAEISS study, NCCH-1512).
Support Care Cancer
; 29(5): 2327-2334, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32918131
4.
11ß hydroxysteroid dehydrogenase 1: a new marker for predicting response to immune-checkpoint blockade therapy in non-small-cell lung carcinoma.
Br J Cancer
; 123(1): 61-71, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32336752
5.
Plasma or Serum: Which Is Preferable for Mutation Detection in Liquid Biopsy?
Clin Chem
; 66(7): 946-957, 2020 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32516802
6.
Axl kinase drives immune checkpoint and chemokine signalling pathways in lung adenocarcinomas.
Mol Cancer
; 18(1): 24, 2019 02 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30744655
7.
Significant differences in T cell receptor repertoires in lung adenocarcinomas with and without epidermal growth factor receptor mutations.
Cancer Sci
; 110(3): 867-874, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30582659
8.
Prognostic Factors and Efficacy of First-Line Chemotherapy in Patients with Advanced Thymic Carcinoma: A Retrospective Analysis of 286 Patients from NEJ023 Study.
Oncologist
; 23(10): 1210-1217, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29567820
9.
Phase II Study of Modified Carboplatin Plus Weekly Nab-Paclitaxel in Elderly Patients with Non-Small Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 1301.
Oncologist
; 22(6): 640-e59, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28526722
10.
Prognostic significance of CpG island methylator phenotype in surgically resected small cell lung carcinoma.
Cancer Sci
; 107(3): 320-5, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26748784
11.
Treatments and outcomes of advanced/recurrent non-small cell lung cancer harboring the EGFR T790M mutation: a retrospective observational study of 141 patients in Japan.
Jpn J Clin Oncol
; 46(12): 1135-1142, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27655904
12.
[Immune Checkpoint Therapy for Non-Small-Cell Lung Cancer].
Gan To Kagaku Ryoho
; 43(6): 666-71, 2016 Jun.
Artículo
en Japonés
| MEDLINE | ID: mdl-27306803
13.
Efficacy of chemotherapy after first-line gefitinib therapy in EGFR mutation-positive advanced non-small cell lung cancer-data from a randomized Phase III study comparing gefitinib with carboplatin plus paclitaxel (NEJ002).
Jpn J Clin Oncol
; 45(7): 670-6, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25877748
14.
[Treatment of advanced non-small-cell lung cancer in elderly patients].
Gan To Kagaku Ryoho
; 42(1): 6-11, 2015 Jan.
Artículo
en Japonés
| MEDLINE | ID: mdl-25596674
15.
Peripheral blood biomarkers associated with combination of immune checkpoint blockade plus chemotherapy in NSCLC.
Cancer Biomark
; 2024 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38669521
16.
Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non-Small Cell Lung Cancer.
JAMA Oncol
; 10(4): 439-447, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38451530
17.
Phase II trial of daily S-1 combined with weekly irinotecan in previously treated patients with advanced or recurrent squamous cell lung cancer: North Japan lung cancer group 1101.
Thorac Cancer
; 14(27): 2804-2810, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37589158
18.
Antibody responses to second doses of COVID-19 vaccination in lung cancer patients undergoing treatment.
Respir Investig
; 61(2): 247-253, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36567161
19.
Monitoring of Plasma EGFR Mutations during Osimertinib Treatment for NSCLC Patients with Acquired T790M Mutation.
Cancers (Basel)
; 15(17)2023 Aug 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37686506
20.
A retrospective study of the efficacy of combined EGFRTKI plus VEGF inhibitor/cytotoxic therapy vs. EGFRTKI monotherapy for PDL1positive EGFRmutant nonsmall cell lung cancer: North Japan Lung Cancer Study Group 2202.
Oncol Lett
; 26(2): 334, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37427337